| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 25.04. | Antibe Therapeutics Inc (2): Antibe Therapeutics to be delisted from TSX May 24 | 3 | Stockwatch | ||
| 24.04. | Antibe Therapeutics Inc (2): Antibe's CCAA proceedings ended, receiver appointed | 1 | Stockwatch | ||
| 24.04. | Antibe Therapeutics Inc. Announces Appointment of Receiver | 31 | Business Wire | TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. ("Antibe" or the "Company") (TSX: ATE) announced that the Company's request for an extension of its previously announced stay of proceedings under... ► Artikel lesen | |
| 19.04. | Antibe Therapeutics Inc (2): Antibe Therapeutics obtains CCAA stay extension | 1 | Stockwatch | ||
| 16.04. | Antibe Therapeutics Inc (2): Antibe Therapeutics under review for listing on TSX | 2 | Stockwatch | ||
| 16.04. | Antibe Therapeutics Inc. Announces TSX Delisting Review | 81 | Business Wire | TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. ("Antibe" or the "Company") (TSX: ATE) announced that the Toronto Stock Exchange ("TSX") is reviewing the eligibility for continued listing on... ► Artikel lesen | |
| 10.04. | Antibe Therapeutics Inc (2): Antibe Therapeutics granted initial order under CCAA | 1 | Stockwatch | ||
| 09.04. | Antibe Therapeutics Inc (2): Antibe Therapeutics under TSX delisting review | 1 | Stockwatch | ||
| 09.04. | Antibe Therapeutics Inc (2): Antibe Therapeutics to resume at 9:15 a.m. PT | 1 | Stockwatch | ||
| 09.04. | Antibe Therapeutics Inc (2): Antibe to file for initial order under CCAA | 1 | Stockwatch | ||
| 09.04. | Antibe Therapeutics Inc (2): Antibe Therapeutics halted at the open | 1 | Stockwatch | ||
| 09.04. | Antibe Therapeutics Inc. Announces Granting of Initial Order Under Companies' Creditors Arrangement Act | 44 | Business Wire | TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. ("Antibe" or the "Company") (TSX: ATE, OTCQX: ATBPF) announced that its previously announced application for an Initial Order under the Companies'... ► Artikel lesen | |
| 01.04. | Antibe Therapeutics Inc (2): Antibe's otenaproxesul placed on clinical hold by FDA | 3 | Stockwatch | ||
| 01.04. | Antibe Therapeutics Inc. Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance | 32 | Business Wire | TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. ("Antibe" or the "Company" TSX: ATE, OTCQX: ATBPF) today announced that it received verbal notice on the afternoon of March 28, 2024 from the... ► Artikel lesen | |
| 04.03. | Antibe Therapeutics placed "Under Review" at Echelon | 2 | Cantech Letter | ||
| 04.03. | Antibe Therapeutics Inc (2): Antibe ordered to refund Nuance's $20M (U.S.) payment | 5 | Stockwatch | ||
| 28.02. | Antibe Therapeutics has more upside still, Paradigm says | 3 | Cantech Letter | ||
| 14.02. | Antibe Therapeutics Inc (2): Antibe spends $2.3-million on R&D in Q3 2024 | 1 | Stockwatch | ||
| 14.02. | Antibe Therapeutics Non-GAAP EPS of -C$0.08 | 1 | Seeking Alpha | ||
| 14.02. | Antibe Therapeutics Inc. Reports Q3 2024 Interim Financial and Operating Results | 164 | Business Wire | TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage biotechnology company leveraging its hydrogen sulfide platform to target pain and inflammation, has... ► Artikel lesen |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 978 |
| EVOTEC | 894 |
| NEL | 887 |
| GAMESTOP | 759 |
| TUI | 605 |
| BAYER | 461 |
| BIONTECH | 384 |
| PLUG POWER | 316 |
| RHEINMETALL | 304 |
| BYD | 272 |
| COMMERZBANK | 267 |
| SUPER MICRO COMPUTER | 250 |
| DEUTSCHE LUFTHANSA | 247 |
| TESLA | 246 |
| DEUTSCHE BANK | 237 |
| MERCEDES-BENZ | 220 |
| VOLKSWAGEN | 213 |
| SIEMENS ENERGY | 208 |
| AIXTRON SE | 195 |
| BASF | 166 |
| ADLER GROUP | 164 |
| ALLIANZ | 162 |
| THYSSENKRUPP | 161 |
| JINKOSOLAR | 149 |
| RWE | 149 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
